Drug Channels delivers timely analysis and provocative opinions from Adam J. Fein, Ph.D., the country's foremost expert on pharmaceutical economics and the drug distribution system. Drug Channels reaches an engaged, loyal and growing audience of more than 35,000 subscribers. Learn more...

Friday, April 09, 2021

A Framework to Optimize Patient Access And Drive Value in the Care Continuum

Today’s guest post comes from William Dupere, Practice Lead and Vice President of Market Access at TrialCard.

Bill discusses specific barriers to access, affordability, and adherence in the specialty pharmacy patient journey. To learn more about TrialCard’s patient access solutions, please visit their Resources page. You can also contact them at sales@trialcard.com.

Read on for Bill’s insights.

Tuesday, April 06, 2021

The Top Pharmacy Benefit Managers of 2020: Vertical Integration Drives Consolidation

The drug channel is consolidating, both vertically and horizontally.

For evidence, look no further than Drug Channels Institute's estimates of pharmacy benefit manager (PBM) market share, which are shown in the chart below. For 2020, DCI estimates that the three biggest PBMs accounted for more than three-quarters of total equivalent prescription claims.

To help you make sense of recent market changes, I also include a brief video explaining how various transactions and partnerships have concentrated and shifted PBM share among the vertically integrated companies. The video is excerpted from my recent Patients, Payers, and PBMs webinar.

Depending on your role in the drug channel, you may or may not find these data terrifying.

Thursday, April 01, 2021

Streamlining the Specialty Therapy Prescribing and Enrollment Experience

Today’s guest post comes from Megan Marchal, CoverMyMeds Specialty Pharmacy’s pharmacist in charge.

Megan discusses a recent enhancement to AMP: Access for More Patients™ (AMP), a tech-enabled hub and patient access service from CoverMyMeds and RxCrossroads by McKesson. Read more about technology and patient access in CoverMyMeds’ 2021 Medication Access Report.

Read on for Megan’s insights.